Veronica Rainone is a Senior Medical Scientist specializing in HIV. They hold a PhD in Molecular Medicine from the University of Milan, where they conducted significant research on the Mucosae-associated Epithelial Chemokine (MEC/CCL28) and its role in HIV vaccine development. Veronica completed a post-doctoral fellowship at the University of Milan, focusing on randomized controlled clinical trials for various treatments, including allergen immunotherapy and stem cell transplantation. In 2022, they served as a Senior Medical Scientist at Gilead Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices